• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
West and Central Africa Pharmaceuticals and Healthcare Report Q4 2012 - Product Image

West and Central Africa Pharmaceuticals and Healthcare Report Q4 2012

  • ID: 2254652
  • October 2012
  • Region: Africa, Central Africa
  • 90 pages
  • Business Monitor International

The West and Central Africa Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on West and Central Africa's pharmaceuticals and healthcare industry.

BMI View:

hold to our view that Cameroon’s medium-to-long-term drug market expansion potential remains highly dependent on the country’s economic growth and is strongly linked to rising income and greater consumer purchasing power. We see Cameroon enjoying above-trend real GDP growth for the next several years as new oil production and a set of major new investments give a temporary boost to the economy. However, the government has limited funds to make the investment needed to improve the healthcare sector. In the meantime, private out-of-pocket expenditure will have to be sufficient to support elevated growth rates in the pharmaceutical market. Irrational consumption of pharmaceuticals,
counterfeit medicines, the very price-sensitive consumer, the prevalence of informal distribution channels and competition with traditional READ MORE >

Note: Product cover images may vary from those shown

Pharmaceuticals Risk/Reward Ratings 5
Table: Pharmaceuticals & Healthcare Q412 Risk/Reward Ratings 5

Cameroon 7

Executive Summary 7

Rewards 8

Risks 9

Market Summary 10

Regulatory Regime 11

Industry Forecast Scenario 12

Overall Market Forecast 12
Table: Pharmaceutical Sales Indicators 2008-2016 14

Key Growth Factors – Healthcare 15
Table: Healthcare Expenditure Indicators 2008-2016 18
Table: Healthcare Governmental Indicators 2008-2016 18
Table: Healthcare Private Indicators 2008-2016 19

Key Growth Factors – Macroeconomic 20

Côte d'Ivoire 29

Executive Summary 29

Pharmaceutical Business Environment Ratings 31

Rewards 32

Risks 32

Market Summary 34
Table: Côte d'Ivoire's Millennium Development Goals 35

Regulatory Regime 40

Pharmacovigilance (PV) 41

Industry Forecast Scenario 43

Overall Market Forecast 43
Table: Pharmaceutical Sales Indicators 2008-2016 44

Key Growth Drivers – Industry 45
Table: Healthcare Expenditure Indicators 2008-2016 46
Table: Healthcare Governmental Indicators 2008-2016 47
Table: Healthcare Private Indicators 2008-2016 47

Key Growth Drivers – Macroeconomic 48

Gabon 53

Executive Summary 54

Pharmaceutical Business Environment Ratings 56

Rewards 56

West & Central Africa Pharmaceuticals & Healthcare Report Q4 2012

© Business Monitor International Ltd

Page 4

Risks 56

Gabon – Market Overview 57

Regulatory Regime 59

Industry Forecast Scenario 60

Overall Market Forecast 60
Table: Pharmaceutical Sales, 2008-2016 61

Key Growth Factors – Industry 62
Table: Overall Healthcare Expenditure, 2008-2016 64
Table: Governmental Healthcare Expenditure, 2008-2016 64
Table: Private Healthcare Expenditure, 2008-2016 65

Epidemiology 66

Key Growth Factors – Macroeconomic 67

Demographic Outlook - Cameroon 72
Table: Population By Age Group, 1990-2020 (‘000) 72
Table: Population By Age Group, 1990-202 0 (% of total) 73
Table: Key Population Ratios, 1990-2020 74
Table: Rural/Urban Population Split, 1990-2020 74

Demographic Outlook - Cote d'Ivoire 76

Côte d'Ivoire's Population By Age Group, 1990-2020 ('000) 77

Côte d'Ivoire's Population By Age Group, 1990-2020 (% of total) 77

Côte d'Ivoire's Key Population Ratios, 1990-2020 78

Côte d'Ivoire's Rural And Urban Population, 1990-2020 78

Demographic Outlook - Gabon 80
Table: Population By Age Group, 1990-2020 (‘000) 80
Table: Population By Age Group, 1990-2020 (% of total) 81
Table: Key Population Ratios, 1990-2020 82
Table: Rural/Urban Population Split, 1990-2020 83

Glossary 84

BMI Methodology 86

How We Generate Our Pharmaceutical Industry Forecasts 86

Risk/Reward Ratings Methodology 87

Ratings Overview 87
Table: Pharmaceutical Business Environment Indicators 88

Weighting 89
Table: Weighting Of Components 89

Sources 89

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos